Filter Results
:
(507)
Show Results For
-
All HBS Web
(507)
- People (2)
- News (133)
- Research (126)
- Events (2)
- Multimedia (5)
- Faculty Publications (68)
Show Results For
-
All HBS Web
(507)
- People (2)
- News (133)
- Research (126)
- Events (2)
- Multimedia (5)
- Faculty Publications (68)
- 20 Nov 2006
- Research & Ideas
Open Source Science: A New Model for Innovation
four-and-a-half year period. Problems involved everything from biotech to consumer products and agrochemicals. Thanks to broadcasting, nearly one-third of the previously unsolved problems found successful solutions. "Innovations...
View Details
Keywords:
by Martha Lagace
- Web
Annual Report 2016 - Annual Report 2016
products giant Faber-Castell and ARRI, the world’s largest manufacturer of professional motion picture equipment. Expanding the I-Lab Ecosystem Work begins on the Pagliuca Harvard Life Lab, a new facility that will offer shared space for high-potential life sciences...
View Details
- 01 Sep 2008
- News
Balanced Equation
significantly. However, we remain a service organization helping entrepreneurs with disruptive technologies that create or transform business. KPCB has always focused on biotech and information technologies. Today we’ve added energy...
View Details
- 25 Feb 2014
- First Look
First Look: February 25
recent firm performance? Purchase this case: http://hbr.org/product/say-on-pay-qualcomm-inc-shareholders-vote-maybe-in-2012/an/114005-PDF-ENG Harvard Business School Case 213-047 Aqua Bounty Valuation of a pre-revenue biotech company at...
View Details
Keywords:
Sean Silverthorne
- 01 Jun 2018
- News
Up by the Roots
establishing a platform for building relationships among the relevant actors—to be a replicable model of ecosystem development that could be applied anywhere, and to any industry. (At the moment, she is attempting to strike gold twice in one place by boosting New...
View Details
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
asking, is this the right business model? But there are no answers. The market and technology are constantly changing," Riesenfeld remarks. Important Sounding Board The biotech industry presents similar challenges in a space littered with...
View Details
- 01 Jun 2011
- News
The Best-Laid Plans
deals with Bed Bath & Beyond, Frontier Airlines, and Johnson & Johnson. “You’re always asking, is this the right business model? But there are no answers. The market and technology are constantly changing,” Riesenfeld remarks. The biotech...
View Details
- 01 Mar 2011
- News
Making Their Way
firm. But when her father fell ill in 1986, the Brownells decided to return to Detroit to help with the family enterprise founded by her great-grandfather. As things turned out, Brownell’s father recovered and was able to continue with the company. But Brownell, who in...
View Details
- 07 Feb 2017
- First Look
First Look at New Research: February 7
case:https://cb.hbsp.harvard.edu/cbmp/product/517027-PDF-ENG Harvard Business School Case 617-022 Alnylam Pharmaceuticals: Building Value from the IP Estate (B) The leader of a pioneering biotech company in the siRNA space weighs his...
View Details
Keywords:
Sean Silverthorne
- 03 May 2011
- First Look
First Look: May 3
Business Model Gary P. Pisano, Ryan Johnson, and Carin-Isabel KnoopHarvard Business School Case 611-046 In the biotech world, the 18-year-old Munich-based company MorphoSys was a rarity: it was profitable. The company achieved this...
View Details
Keywords:
Sean Silverthorne
- 01 Dec 2010
- News
This Is What I Do
thus deserve our support.” The MJFF raises about $50 million a year. There are prominent backers, such as Google’s Sergey Brin and his wife, Anne Wojcicki, but nearly 55,000 other people made contributions last year. To date the MJFF has supported about ninety View Details
- 17 Mar 2009
- First Look
First Look: March 17, 2009
Download the paper: http://www.hbs.edu/research/pdf/09-099.pdf Cases & Course MaterialsAvid Radiopharmaceuticals: The Venture Debt Question Harvard Business School Case 809-086 The CEO of a promising biotech company must decide how...
View Details
Keywords:
Martha Lagace
- 29 Oct 2000
- Research & Ideas
The Entrepreneurial Venture: A Conversation
decisions? O'Lear: I have been involved in microeconomic (company specific) upheaval. Prior to starting a company with two others, I worked at two high-tech companies: a privately held cardiac ultrasound imaging company and a VC-backed View Details
Keywords:
by Susan Young
- 12 May 2009
- First Look
First Look: May 12, 2009
this situation, donations are likely to decline, investment surplus has declined and biotech partners are challenged to finance joint projects as well as their own operations. Beall is striving to find a cure for cystic fibrosis while...
View Details
Keywords:
Martha Lagace
- 01 Sep 2009
- News
E Ink’s Wild Ride
that required a massive amount of investment before it could take off,” says Yoffie, who served on E Ink’s board from 1999 to 2004. “The truism is that getting to that point takes longer and costs more money than the most pessimistic forecast. It’s a very similar...
View Details
- 28 Aug 2012
- First Look
First Look: August 28
determining a new venture's future alliance formation diminishes as the new venture's prominence in alliance networks increases. Evidence from biotech alliances between new ventures and established companies provides support for our...
View Details
Keywords:
Sean Silverthorne
- 28 Apr 2009
- First Look
First Look: April 28, 2009
testing, and business strategy at Targanta Therapeutics, a biotech company preparing its first new drug application to the FDA. In October 2007, Mark Leuchtenberger, president and CEO of Targanta—which has just held a successful...
View Details
Keywords:
Martha Lagace
- Web
Annual Report 2017 - Annual Report 2017
press release Pagliuca Harvard Life Lab The newest addition to the Harvard Innovation Lab (i-lab) ecosystem, the Life Lab—made possible by a gift from Judy (MBA 1983) and Steve (MBA 1982) Pagliuca—offers shared space for high-potential life sciences and View Details
- 04 Jun 2007
- Research & Ideas
Is Health Care Making You Better—or Dead?
technological innovation, which is how the biotechs and some of the medical devices can get through these hurdles. But for a health service innovation, the payment hurdles are so massive it's masochistic. Then if you go into competition...
View Details
- 21 Apr 2009
- First Look
First Look: April 21, 2009
this case: http://harvardbusinessonline.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=807106 Note on Biotech Business Development Harvard Business School Note 807-032 Describes the business development process in biotechnology...
View Details
Keywords:
Martha Lagace